XML 48 R38.htm IDEA: XBRL DOCUMENT
v3.25.3

INVESTMENTS – RELATED PARTIES (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] |
Schedule of investment |
Schedule of investment |  |  |  |  |  |  |  |  |  |  |  |
|  | Interest |  |  |  | September 30, |  |  | December 31, |
|  | Rate |  | Due Date |  | 2025 |  |  | 2024 |
Promissory note and accrued interest receivable, Ault & Company |  | 8% |  | December 31, 2024 |  | $ | - |  |  | $ | 2,468,000 |
Promissory notes and accrued interest receivable, GIGA |  | 6% - 15% |  | In bankruptcy |  |  | 27,761,000 |  |  |  | 18,499,000 |
Other |  |  |  |  |  |  | 335,000 |  |  |  | 335,000 |
Allowance for credit losses |  |  |  |  |  |  | (500,000 | ) |  |  | (500,000 | )
Total investment in promissory notes and other, related parties |  |  |  |  |  | $ | 27,596,000 |  |  | $ | 20,802,000 |
Schedule of Interest income, related party |
Schedule of Interest income, related party |  |  |  |  |  |  |  |  |  |  |  |
|  | For the Three Months Ended |  |  | For the Nine Months Ended |
|  | September 30, |  |  | September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Interest income, related party |  | $ | 566,000 |  |  | $ | 337,000 |  |  | $ | 1,714,000 |  |  | $ | 815,000 |
Schedule of investment in common stock |
Schedule of investment in common stock |  |  |  |  |  |  |  |  |
|  | Investments in Common Stock, Related Parties at September 30, 2025 |
|  | Cost |  |  | Gross Unrealized Losses |  |  | Fair value |
Common shares |  | $ | 24,394,000 |  |  | $ | (24,310,000 | ) |  | $ | 84,000 |
Alzamend series B convertible preferred stock, warrants |  |  | 839,000 |  |  |  | - |  |  |  | 839,000 |
|  | $ | 25,233,000 |  |  | $ | (24,310,000 | ) |  | $ | 923,000 |
|  | Investments in Common Stock, Related Parties at December 31, 2024 |
|  | Cost |  |  | Gross Unrealized Losses |  |  | Fair value |
Common shares |  | $ | 24,697,000 |  |  | $ | (24,607,000 | ) |  | $ | 90,000 |
Alzamend series B convertible preferred stock, warrants |  |  | 2,100,000 |  |  |  | - |  |  |  | 2,100,000 |
|  | $ | 26,797,000 |  |  | $ | (24,607,000 | ) |  | $ | 2,190,000 |
Schedule of investment in warrants and common stock |
Schedule of investment in warrants and common stock |  |  |  |  |  |  |  |
|  | For the Three Months Ended September 30, |
|  | 2025 |  |  | 2024 |
Balance at July 1 |  | $ | 24,000 |  |  | $ | 304,000 |
Conversion of Alzamend series B convertible preferred stock to common stock |  |  | 1,261,000 |  |  |  | - |
Sale of Alzamend common stock |  |  | (1,268,000 | ) |  |  | - |
Realized gain in common stock of Alzamend |  |  | 70,000 |  |  |  | - |
Unrealized loss in common stock of Alzamend |  |  | (3,000 | ) |  |  | (173,000 | )
Balance at September 30 |  | $ | 84,000 |  |  | $ | 131,000 |
The following tables summarize the changes in the Company’s investments in Alzamend common stock during the nine months ended September 30, 2025 and 2024:
|  | For the Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |
Balance at January 1 |  | $ | 90,000 |  |  | $ | 679,000 |
Investment in common stock of Alzamend |  |  | 8,000 |  |  |  | 9,000 |
Conversion of Alzamend series B convertible preferred stock to common stock |  |  | 1,261,000 |  |  |  | - |
Sale of Alzamend common stock |  |  | (1,274,000 | ) |  |  | - |
Realized loss in common stock of Alzamend |  |  | (298,000 | ) |  |  | - |
Unrealized gain (loss) in common stock of Alzamend |  |  | 297,000 |  |  |  | (557,000 | )
Balance at September 30 |  | $ | 84,000 |  |  | $ | 131,000 |
Schedule of investment in warrants and preferred stock |
Schedule of investment in warrants and preferred stock |  |  |  |  |  |  |  |
|  | September 30, |  |  | December 31, |
|  | 2025 |  |  | 2024 |
Investment in Alzamend preferred stock |  | $ | 839,000 |  |  | $ | 2,100,000 |
Total investment in other investments securities, related party |  | $ | 839,000 |  |  | $ | 2,100,000 |

X
- References No definition available. + Details
Name: | gpus_InvestmentHoldingsScheduleOfInvestmentsOneTableTextBlock
Namespace Prefix: | gpus_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | gpus_ScheduleOfInterestIncomeRelatedPartyTableTextBlock
Namespace Prefix: | gpus_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | gpus_ScheduleOfInvestmentInWarrantsAndCommonStockTableTextBlock
Namespace Prefix: | gpus_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | gpus_ScheduleOfInvestmentInWarrantsAndPreferredStockTableTextBlock
Namespace Prefix: | gpus_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | srt_SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 321 -Publisher FASB -URI https://asc.fasb.org/321/tableOfContent Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 325 -Publisher FASB -URI https://asc.fasb.org/325/tableOfContent + Details
Name: | us-gaap_InvestmentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration